Cytokinetics Stock (NASDAQ: CYTK) stock price, news, charts, stock research, profile.
You can purchase shares of Cytokinetics (NASDAQ:CYTK) through any online brokerage.
Other companies in Cytokinetics’s space includes: Legend Biotech (NASDAQ:LEGN), Ultragenyx Pharmaceutical (NASDAQ:RARE), Exact Sciences (NASDAQ:EXAS), Ionis Pharmaceuticals (NASDAQ:IONS) and Roivant Sciences (NASDAQ:ROIV).
Cytokinetics has a consensus price target of $80.17.
The stock price for Cytokinetics (NASDAQ: CYTK) is $48.8695 last updated December 20, 2024 at 4:00 PM EST.
There are no upcoming dividends for Cytokinetics.
Cytokinetics’s Q4 earnings are confirmed for Tuesday, February 25, 2025.
There is no upcoming split for Cytokinetics.
Cytokinetics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.